公开(公告)号：US20150297596A1

公开(公告)日：2015-10-22

申请号：US14696680

申请日：2015-04-27

Applicant: ABBVIE INC.

Inventor： David J. Calderwood ,  Eric C. Breinlinger ,  Steven L. Swann ,  Subhendu Mukherjee ,  Venkata Srikanth Chitty ,  Siva Sanjeeva Rao Thunuguntla ,  Subramanya Seetharama Shastry Hosahalli

IPC: A61K31/506 ,  A61K31/541 ,  A61K31/5377

CPC classification number: A61K31/506 ,  A61K31/5377 ,  A61K31/541 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  Y02A50/401 ,  Y02A50/463 ,  Y02A50/481

Abstract: The present invention provides compound of Formula (I) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions.

Abstract translation: 本发明提供式（I）化合物的生物活性代谢物，前药，异构体，立体异构体，溶剂合物，水合物及其药学上可接受的盐，其中变量在本文中定义。 本发明的化合物可用于治疗免疫学病症。